Skip to main content

Home
Courses

Home
Courses

Logout

Logout

Training catalogue

Filters

Visibility

- Any -

All trainings

My trainings

Categories

Anti-Infectives

Inflammation and Immunology

Internal Medicine

Oncology

Rare Diseases

Brands

Eliquis

Ibrance

Lorlak

Prevenar 13

Tygacil

Zavicefta

Status

Finished

In progress

To start

Passed

Failed

Sort

Manajemen Gangguan Irama Jantung (Fibrilasi Atrium) dengan Terapi NOAC

Eliquis - Internal Medicine

Learn more

Helping Prevent Pneumococcal Disease in Children

Prevenar 13

Learn more

Prevenar 13 Strong Legacy and Heritage Against Pneumococcal Disease in Adult Patient

Prevenar 13

Learn more

Ceftazidime Avibactam untuk Infeksi Bakteri Gram Negatif Multidrug-Resistant

Zavicefta Tygacil - Anti-Infectives

Learn more

0%

CROWN Study in-Depth: 3 Years Follow Up Data of Lorlatinib in 1st Line ALK+ NSCLC

Lorlak - Oncology

Learn more

First-in-class CDK4/6 inhibitor Palbociclib in treating broad range of women with HR+, HER2- metastatic Breast Cancer

Ibrance - Oncology

Learn more

PT Pfizer Indonesia
28th Floor World Trade Center 3
Jl. Jend. Sudirman Kav.29-31,
Jakarta 12920, Indonesia
Telp: +62-21-8086 1400
PP-UNP-IDN-0203-FEB-2023

For healthcare professionals only